SPIE SA (SPIE.PA)

FR0012757854 - Common Stock

29.22  -0.22 (-0.75%)

Fundamental Rating

5

SPIE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 46 industry peers in the Commercial Services & Supplies industry. While SPIE is still in line with the averages on profitability rating, there are concerns on its financial health. SPIE is not valued too expensively and it also shows a decent growth rate.



6

1. Profitability

1.1 Basic Checks

In the past year SPIE was profitable.
SPIE had a positive operating cash flow in the past year.
SPIE had positive earnings in each of the past 5 years.
In the past 5 years SPIE always reported a positive cash flow from operatings.

1.2 Ratios

SPIE has a Return On Assets (2.31%) which is comparable to the rest of the industry.
The Return On Equity of SPIE (11.64%) is better than 61.90% of its industry peers.
SPIE has a Return On Invested Capital of 6.02%. This is comparable to the rest of the industry: SPIE outperforms 57.14% of its industry peers.
SPIE had an Average Return On Invested Capital over the past 3 years of 5.25%. This is below the industry average of 7.66%.
The last Return On Invested Capital (6.02%) for SPIE is above the 3 year average (5.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.31%
ROE 11.64%
ROIC 6.02%
ROA(3y)2.09%
ROA(5y)1.75%
ROE(3y)10.11%
ROE(5y)8.83%
ROIC(3y)5.25%
ROIC(5y)4.73%

1.3 Margins

The Profit Margin of SPIE (2.40%) is comparable to the rest of the industry.
SPIE's Profit Margin has improved in the last couple of years.
SPIE has a Operating Margin (5.24%) which is comparable to the rest of the industry.
SPIE's Operating Margin has improved in the last couple of years.
SPIE has a Gross Margin (40.38%) which is in line with its industry peers.
SPIE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.24%
PM (TTM) 2.4%
GM 40.38%
OM growth 3Y13.03%
OM growth 5Y5.09%
PM growth 3Y50.68%
PM growth 5Y14.88%
GM growth 3Y-1.1%
GM growth 5Y1.3%

2

2. Health

2.1 Basic Checks

SPIE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SPIE has been increased compared to 1 year ago.
Compared to 5 years ago, SPIE has more shares outstanding
Compared to 1 year ago, SPIE has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that SPIE is in the distress zone and has some risk of bankruptcy.
SPIE has a Altman-Z score (1.47) which is comparable to the rest of the industry.
SPIE has a debt to FCF ratio of 3.78. This is a good value and a sign of high solvency as SPIE would need 3.78 years to pay back of all of its debts.
SPIE's Debt to FCF ratio of 3.78 is fine compared to the rest of the industry. SPIE outperforms 73.81% of its industry peers.
A Debt/Equity ratio of 1.10 is on the high side and indicates that SPIE has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.10, SPIE is doing worse than 64.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 3.78
Altman-Z 1.47
ROIC/WACC0.97
WACC6.22%

2.3 Liquidity

A Current Ratio of 0.79 indicates that SPIE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.79, SPIE is doing worse than 85.71% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that SPIE may have some problems paying its short term obligations.
The Quick ratio of SPIE (0.77) is worse than 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.77

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.01% over the past year.
The Earnings Per Share has been growing by 19.93% on average over the past years. This is quite good.
The Revenue has grown by 9.23% in the past year. This is quite good.
SPIE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.44% yearly.
EPS 1Y (TTM)45.01%
EPS 3Y61.76%
EPS 5Y19.93%
EPS Q2Q%-21.84%
Revenue 1Y (TTM)9.23%
Revenue growth 3Y9.43%
Revenue growth 5Y5.44%
Sales Q2Q%118.03%

3.2 Future

Based on estimates for the next years, SPIE will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.56% on average per year.
Based on estimates for the next years, SPIE will show a small growth in Revenue. The Revenue will grow by 5.18% on average per year.
EPS Next Y23.32%
EPS Next 2Y17.1%
EPS Next 3Y13.56%
EPS Next 5YN/A
Revenue Next Year13.6%
Revenue Next 2Y10.03%
Revenue Next 3Y8.06%
Revenue Next 5Y5.18%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.97 indicates a rather expensive valuation of SPIE.
SPIE's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of SPIE to the average of the S&P500 Index (26.91), we can say SPIE is valued inline with the index average.
With a Price/Forward Earnings ratio of 10.05, the valuation of SPIE can be described as very reasonable.
Based on the Price/Forward Earnings ratio, SPIE is valued a bit cheaper than the industry average as 64.29% of the companies are valued more expensively.
SPIE is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.26, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 21.97
Fwd PE 10.05

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SPIE is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SPIE indicates a somewhat cheap valuation: SPIE is cheaper than 76.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.57
EV/EBITDA 8.8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SPIE has a very decent profitability rating, which may justify a higher PE ratio.
SPIE's earnings are expected to grow with 13.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.94
PEG (5Y)1.1
EPS Next 2Y17.1%
EPS Next 3Y13.56%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.92%, SPIE has a reasonable but not impressive dividend return.
SPIE's Dividend Yield is rather good when compared to the industry average which is at 3.91. SPIE pays more dividend than 80.95% of the companies in the same industry.
SPIE's Dividend Yield is a higher than the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.92%

5.2 History

On average, the dividend of SPIE grows each year by 6.15%, which is quite nice.
Dividend Growth(5Y)6.15%
Div Incr Years4
Div Non Decr Years4

5.3 Sustainability

62.14% of the earnings are spent on dividend by SPIE. This is not a sustainable payout ratio.
The dividend of SPIE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.14%
EPS Next 2Y17.1%
EPS Next 3Y13.56%

SPIE SA

EPA:SPIE (1/13/2025, 5:35:15 PM)

29.22

-0.22 (-0.75%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)10-31 2024-10-31
Earnings (Next)N/A N/A
Inst Owners48.33%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap4.94B
Analysts84.44
Price Target41.77 (42.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.92%
Dividend Growth(5Y)6.15%
DP62.14%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.54%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE 21.97
Fwd PE 10.05
P/S 0.53
P/FCF 6.57
P/OCF 5.91
P/B 2.59
P/tB N/A
EV/EBITDA 8.8
EPS(TTM)1.33
EY4.55%
EPS(NY)2.91
Fwd EY9.95%
FCF(TTM)4.45
FCFY15.23%
OCF(TTM)4.94
OCFY16.91%
SpS54.78
BVpS11.29
TBVpS-17.64
PEG (NY)0.94
PEG (5Y)1.1
Profitability
Industry RankSector Rank
ROA 2.31%
ROE 11.64%
ROCE 9.36%
ROIC 6.02%
ROICexc 6.58%
ROICexgc N/A
OM 5.24%
PM (TTM) 2.4%
GM 40.38%
FCFM 8.12%
ROA(3y)2.09%
ROA(5y)1.75%
ROE(3y)10.11%
ROE(5y)8.83%
ROIC(3y)5.25%
ROIC(5y)4.73%
ROICexc(3y)6.94%
ROICexc(5y)6.16%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.13%
ROCE(5y)7.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y20.79%
ROICexc growth 5Y9.6%
OM growth 3Y13.03%
OM growth 5Y5.09%
PM growth 3Y50.68%
PM growth 5Y14.88%
GM growth 3Y-1.1%
GM growth 5Y1.3%
F-Score4
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 3.78
Debt/EBITDA 2.55
Cap/Depr 24.39%
Cap/Sales 0.89%
Interest Coverage 250
Cash Conversion 101.22%
Profit Quality 338.43%
Current Ratio 0.79
Quick Ratio 0.77
Altman-Z 1.47
F-Score4
WACC6.22%
ROIC/WACC0.97
Cap/Depr(3y)24.6%
Cap/Depr(5y)27.92%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.89%
Profit Quality(3y)292.1%
Profit Quality(5y)409.24%
High Growth Momentum
Growth
EPS 1Y (TTM)45.01%
EPS 3Y61.76%
EPS 5Y19.93%
EPS Q2Q%-21.84%
EPS Next Y23.32%
EPS Next 2Y17.1%
EPS Next 3Y13.56%
EPS Next 5YN/A
Revenue 1Y (TTM)9.23%
Revenue growth 3Y9.43%
Revenue growth 5Y5.44%
Sales Q2Q%118.03%
Revenue Next Year13.6%
Revenue Next 2Y10.03%
Revenue Next 3Y8.06%
Revenue Next 5Y5.18%
EBIT growth 1Y8.59%
EBIT growth 3Y23.69%
EBIT growth 5Y10.81%
EBIT Next Year74.3%
EBIT Next 3Y26.2%
EBIT Next 5YN/A
FCF growth 1Y53.45%
FCF growth 3Y9.64%
FCF growth 5Y15.83%
OCF growth 1Y48.52%
OCF growth 3Y8.39%
OCF growth 5Y14.3%